Regulon

Regulon: R-1928

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.2625119Pr-85Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
6720 ENSG00000072310 SREBF1 P36956
5372 ENSG00000100417 PMM1 Q92871
64838 ENSG00000115226 FNDC4 Q9H6D8
84263 ENSG00000119471 HSDL2 Q6YN16
3764 ENSG00000121361 KCNJ8 Q15842
1026 ENSG00000124762 CDKN1A P38936
5538 ENSG00000131238 PPT1 P50897
3685 ENSG00000138448 ITGAV P06756
388 ENSG00000143878 RHOB P62745
23704 ENSG00000152049 KCNE4 A5H1P5
55788 ENSG00000168216 LMBRD1 Q9NUN5
4493 ENSG00000169715 MT1E P04732
5500 ENSG00000213639 PPP1CB P62140

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ATN-161ITGB3ProteinANTAGONISTIntegrin alpha-5/beta-1 antagonist20
IMGN-388ITGAVAntibodyBINDING AGENTVitronectin receptor alpha binding agent10
CILENGITIDEITGAVProteinANTAGONISTIntegrin alpha-V/beta-3 antagonist33
ABCIXIMABITGB3AntibodyINHIBITORIntegrin alpha-V/beta-3 inhibitor40
DIAZOXIDEKCNJ8Small moleculeOPENERPotassium channel, inwardly rectifying, subfamily J, member 11 opener40
ETARACIZUMABITGB3AntibodyANTAGONISTIntegrin alpha-V/beta-3 antagonist20
INTETUMUMABITGAVAntibodyANTAGONISTIntegrin alpha-V/beta-3 antagonist20
STX-100ITGAVAntibodyINHIBITORIntegrin alpha-V/beta-6 inhibitor20
ABITUZUMABITGAVAntibodyINHIBITORIntegrin alpha-V/beta-5 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-1928

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00301SPTA1down-regulatesHBP1activatesR-1928125Drugs (9)
CMF-03496SLC4A10up-regulatesHBP1activatesR-1928123Drugs (9)
CMF-04176ESPNPup-regulatesHBP1activatesR-1928123Drugs (9)
CMF-04499MYH8up-regulatesHBP1activatesR-1928125Drugs (9)
CMF-17815ANO2down-regulatesHBP1activatesR-1928122Drugs (9)
CMF-24698SCN5Adown-regulatesHBP1activatesR-1928122Drugs (9)
CMF-36854MYOM2down-regulateshsa-mir-130brepressesR-192893Drugs (9)
CMF-38835CDH18down-regulateshsa-mir-130brepressesR-192895Drugs (9)
CMF-33475TCR_SIGNALING_IN_NAIVE_CD4+_T_CELLSup-regulatesHBP1activatesR-1928127Drugs (9)